Table 1.
Patient Clinical Information
| Variables: Median (range) | Patients (n=15) |
|---|---|
| Age (years) | 59.86(41–84) |
| ER(-/+) | - (n=7) |
| + (n=8) | |
| AR(-/+) | - (n=8) |
| + (n=7) | |
| PR(-/+) | - (n=5) |
| + (n=10) | |
| HER2 | + (n=3) |
| ++ (n=8) | |
| +++ (n=4) | |
| Ki-67 | <15% (n=3) |
| ≥15% (n=12) | |
| Tumor size | ≤2cm (n=10) |
| >2cm (n=5) | |
| TNM stage | Stage I (n=8) |
| Stage II (n=6) | |
| Stage III (n=1) |
Abbreviations: ER, estrogen receptor; AR, androgen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor; Ki-67, Ki-67 Antigen; TNM, tumor node metastasis.